Revenue Breakdown
Composition ()
No data
Revenue Streams
United-Guardian Inc (UG) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Pharmaceutical, accounting for 47.1% of total sales, equivalent to $1.17M. Other significant revenue streams include Cosmetic Ingredients and Medical. Understanding this composition is critical for investors evaluating how UG navigates market cycles within the Pharmaceuticals industry.
Profitability & Margins
Evaluating the bottom line, United-Guardian Inc maintains a gross margin of 42.09%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 9.50%, while the net margin is 11.86%. These profitability ratios, combined with a Return on Equity (ROE) of 17.85%, provide a clear picture of how effectively UG converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, UG competes directly with industry leaders such as ORGN and NXGL. With a market capitalization of $31.98M, it holds a leading position in the sector. When comparing efficiency, UG's gross margin of 42.09% stands against ORGN's -57.53% and NXGL's 42.37%. Such benchmarking helps identify whether United-Guardian Inc is trading at a premium or discount relative to its financial performance.
